1. Home
  2. IMNM vs SVM Comparison

IMNM vs SVM Comparison

Compare IMNM & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.35

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$10.61

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
SVM
Founded
2006
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
IMNM
SVM
Price
$19.35
$10.61
Analyst Decision
Strong Buy
Hold
Analyst Count
10
1
Target Price
$32.80
$10.50
AVG Volume (30 Days)
1.3M
4.0M
Earning Date
05-08-2026
05-25-2026
Dividend Yield
N/A
0.22%
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
N/A
Revenue This Year
N/A
$36.87
Revenue Next Year
$1,127.34
$35.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.96
$4.03
52 Week High
$27.65
$15.77

Technical Indicators

Market Signals
Indicator
IMNM
SVM
Relative Strength Index (RSI) 46.93 42.44
Support Level $19.28 $9.66
Resistance Level $23.00 $13.57
Average True Range (ATR) 0.84 0.75
MACD 0.21 -0.07
Stochastic Oscillator 49.16 31.09

Price Performance

Historical Comparison
IMNM
SVM

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

Share on Social Networks: